ARCA biopharma Total Current Liabilities 2011-2026 | ABIO

Annual Total Current Liabilities ARCA biopharma

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
13 M	637 K	1.13 M	3.5 M	3.5 M	926 K	793 K	2.07 M	2.4 M	1.5 M	1.39 M	1.5 M	305 K	754 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
13 M	305 K	2.39 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Aptorum Group Limited APM	4.34 M	$ 0.82	-3.48 %	$ 4.47 M	China
Rigel Pharmaceuticals RIGL	99.2 M	$ 33.23	-4.03 %	$ 584 M	USA
Graybug Vision GRAY	3.78 M	-	-11.23 %	$ 9.65 M	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	19 M	-	2.71 %	$ 14 M	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Apellis Pharmaceuticals APLS	324 M	$ 20.15	-2.68 %	$ 2.54 B	USA
AbCellera Biologics ABCL	64.3 M	$ 3.72	-2.75 %	$ 1.11 B	Canada
Athersys ATHX	29.9 M	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
AVEO Pharmaceuticals AVEO	18.7 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	379 M	$ 163.7	-1.61 %	$ 8.14 B	USA
BridgeBio Pharma BBIO	288 M	$ 64.66	-1.37 %	$ 12.4 B	USA
Brainstorm Cell Therapeutics BCLI	8.98 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	82.4 M	-	-4.8 %	$ 255 M	USA
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	36.8 M	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Avid Bioservices CDMO	70.6 M	-	-	$ 789 M	USA
Certara CERT	153 M	$ 7.16	1.49 %	$ 1.15 B	USA
Checkpoint Therapeutics CKPT	20.1 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	5.61 M	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	58 M	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	125 M	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Checkmate Pharmaceuticals CMPI	9.38 M	-	-	$ 231 M	USA
Capricor Therapeutics CAPR	31.3 M	$ 25.91	-3.56 %	$ 694 M	USA
Catalyst Pharmaceuticals CPRX	147 M	$ 24.0	0.5 %	$ 2.93 B	USA
Acasti Pharma ACST	1.93 M	-	4.01 %	$ 150 M	Canada
Codexis CDXS	23.6 M	$ 0.99	-3.28 %	$ 72.7 M	USA
Corvus Pharmaceuticals CRVS	6.87 M	$ 17.75	-0.79 %	$ 852 M	USA
CTI BioPharma Corp. CTIC	81.1 M	-	-	$ 1.2 B	USA
CohBar CWBR	3.07 M	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	6.27 M	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	6.27 M	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	100 M	-	-	$ 2.18 B	USA
Denali Therapeutics DNLI	102 M	$ 20.02	-4.67 %	$ 3.29 B	USA
AgeX Therapeutics AGE	5.91 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Eton Pharmaceuticals ETON	16.2 M	$ 17.54	-3.36 %	$ 450 M	USA
Entasis Therapeutics Holdings ETTX	9.71 M	-	-	$ 105 M	USA
Evofem Biosciences EVFM	72.5 M	-	7.55 %	$ 38.1 M	USA